It is reported that IGF2BP1 accelerated melanoma cell metastasis and target inhibition enhances the effects of BRAF-inhibitor and BRAF-MEK inhibitors in BRAF mutation melanoma [40, 41]. This evidence concerns the gene MAP2K7 and melanoma.